Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Diazoxide Choline in Non-Diabetic Hypertriglyceridemic Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Diazoxide (Primary)
- Indications Hyperlipoproteinaemia type V; Hypertriglyceridaemia
- Focus Therapeutic Use
- 17 May 2009 Primary endpoint 'Triglyceride levels' has been met, according to an Essentialis Therapeutics media release.
- 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Nov 2008 Enrollment in this trial has been completed, according to an Essentialis media release. 92 patients have been enrolled.